AI Synergy – How AI Collaborations are Shaping the Future
When technological advances are not just progressions but revolutions, the concept of “AI to AI” is beginning to make itself felt on several levels. T…
When technological advances are not just progressions but revolutions, the concept of “AI to AI” is beginning to make itself felt on several levels. T…
In the rapidly evolving landscape of healthcare, this year will bring forward some major advancements and transformative trends. As we delve into the …
Dive into a world where technology meets healthcare in our comprehensive list of 2024 upcoming events and conferences. From groundbreaking advance…
Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and diagnostics, today announced that they have been chosen by the United States Department of Defense (DoD) Defense Health Agency’s Posttraumatic Stress Disorder Drug Treatment Program as a technology partner for a clinical study aimed at developing new therapies to treat PTSD.
Visage has unveiled Visage Ease VP, software tailored for Apple's newly launched spatial computing platform, Apple Vision Pro. Designed to unleash the…
The University of Rochester Medical Center today announced a first-of-its-kind initiative to improve health care access and wellness outcomes in rural communities in Upstate New York through the distribution of telehealth stations conveniently located at local bank branches.
Cedars-Sinai, a renowned healthcare institution, introduces a groundbreaking application leveraging Apple Vision Pro technology to provide unparallele…
Program drives increased education and access to high-quality testing for early detection to protect kidney health and lower healthcare costsAUSTIN, Texas--(BUSINESS WIRE)--Everly Health, a leading remote-based healthcare company expanding access to v...
Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision and ability to successfully execute its mission to revolutionize arrhythmia care.
Data from the first US comprehensive single center experience at St Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session at the AF Symposium 2024 in Boston, shows that Left Atrial Appendage Occlusion (LAAO) procedures planned by means of FEops HEARTguideTM result in significantly improved procedural efficiency.